Clinical Trials Logo

Cytokines clinical trials

View clinical trials related to Cytokines.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06250075 Completed - Gastric Cancer Clinical Trials

Effects of the Use of Probiotics on the Intestinal Microbiota of Patients With Gastric Cancer

PRONIC-G
Start date: December 12, 2020
Phase: N/A
Study type: Interventional

The objective of this randomized controlled, prospective clinical study, composed of 5 groups, G1, G2, G3, G4 and G5 is [Evaluate the intestinal microbiota profile, nutritional, immunological status and inflammatory profile, before and after total or partial removal surgery (gastrectomies) for gastric cancer, in a patient using probiotic supplements.] The main questions it aims to answer are: - probiotics are capable of modulating the immune response and microbiota in cancer patients who will undergo surgery - surgery itself alters the immunological pattern and microbiota of cancer patients Participants will be divided into groups for evaluation and the G1 intervention group will take probiotic capsules. The researchers will compare groups G1, G2 with G3 (negative control group) to see if there are differences between using probiotics or not, in controlling the immune response and if there are significant changes in their intestinal microbiota. Groups G4 and G5 will also be compared, where in these we will only measure the power of the use of probiotics in reducing surgical complications in the postoperative period.

NCT ID: NCT04865510 Completed - Acute Kidney Injury Clinical Trials

Citrate Versus Heparin in Continuous Renal Replacement Therapy :

Start date: February 4, 2019
Phase: N/A
Study type: Interventional

This study is a prospective, multicenter, open-label randomized trial comparing regional citrate anticoagulation (RCA) with heparin-free protocol. The function mode was continuous venovenous hemodiafiltration (CVVHDF) in post-dilution mode. The investigators measured hemodynamic changes at certain time points after starting CRRT (0, 6, 12, 24, 48, 72 hr).Levels of inflammatory cytokine (IL-1β, IL-6, IL-8, IL-10 and TNF-ɑ) were measured at day 1 and day 3

NCT ID: NCT04562376 Completed - Multiple Sclerosis Clinical Trials

High-intensity Resistance Training in People With Multiple Sclerosis Experiencing Fatigue

Start date: August 20, 2020
Phase: N/A
Study type: Interventional

Fatigue is one of the most frequently reported and disabling impairments in multiple sclerosis (MS) and is associated with activity limitations, participation restrictions and reduced health-related quality of life (HRQL).MS fatigue is thought to be related to the disease itself, where increased levels of inflammatory biological markers (cytokines) are contributing. Resistance training may have an anti-inflammatory effect where a higher intensity is thought to have a more profound effect. Moderate-intensity resistance training is well tolerated in people with MS (PwMS) and can reduce self-reported fatigue. There is, however, a lack of high-quality studies including only fatigued PwMS when evaluating exercise regimes. Furthermore, the optimal dose (i.e. the combination of duration, frequency and intensity) is not known. Our hypothesis is that high-intensity resistance training will have positive effects in fatigued PwMS on functioning (fatigue, mood, activities and participation) and wellbeing/HRQL; and a positive immunomodulatory effect measured by inflammatory biological markers in blood. Further, that high-intensity resistance training twice a week will be superior to once a week

NCT ID: NCT04483271 Completed - Cytokine Storm Clinical Trials

The Effect of Omega-3 on Selected Cytokines Involved in Cytokine Storm

Start date: October 2, 2020
Phase: N/A
Study type: Interventional

The trial was designed to assess the effect of daily dose of 300 mg omega-3 supplements for 2 months on the selected interleukins levels in uninfected people with Covid-19.

NCT ID: NCT04293380 Completed - Down Syndrome Clinical Trials

Amniotic Fluid Ischemia Modified Albumin as a Novel e Prenatal Diagnostic Marker for Down Syndrome

Start date: March 1, 2012
Phase: N/A
Study type: Interventional

Down syndrome is the most common genetic disorder in the society that causes mental retardation. Today, screening tests (combined test, triple screening, ultrasonography and age) are performed for the diagnosis of down syndrome for all pregnant women. As a result of screening tests, amniocentesis is performed as a diagnostic test for the group at risk. Chromosome analysis from amniotic fluid requires a 3-week period for chromosome cultures to yield results. Several levels of biochemical markers, such as organic acids and pyridoxine metabolites, have been found to be elevated in the amniotic fluid. The investigators also plan to investigate ischemia-modified albumin, hepatocyte growth factor level in amniotic fluid.

NCT ID: NCT04226573 Completed - Clinical trials for Preoperative Anxiety

Effect of Preoperative Anxiety on Fetus in Pregnant Women

Start date: February 1, 2020
Phase:
Study type: Observational

In the preoperative period, 60-80% of the patients had anxiety symptoms. This rate increases even more during pregnancy. There are a number of studies examining the role of anxiety symptoms on fetal outcome, but the mechanisms that explain the effects of maternal stress are not fully understood. The most extensively studied cytokines in neuropsychiatric disorders are TNF-α and IL-6 due to their effects on the central nervous system. TNF-α levels have been reported to be elevated in anxiety disorders. In our study, the investigators aimed to determine the relationship between preoperative anxiety levels and fetal cord blood TNF-α and IL-6 cytokine levels in pregnant women.

NCT ID: NCT03264846 Completed - Clinical trials for Polycystic Ovary Syndrome

Endocan Levels at Polycystic Ovary Syndrome and Periodontal Inflammation

Start date: April 3, 2017
Phase:
Study type: Observational [Patient Registry]

Periodontal diseases are chronic inflammatory disease occurred by the interaction between pathogenic microorganism and the host defense. Polycystic ovary syndrome (PCOS) is a reproductive and metabolic disease associated with increased risk of cardiovascular events. Endocan is a proteoglycan secreted mainly by endothelial cells under the control of inflammatory cytokines. Periodontal diseases, including gingivitis, are common chronic infectious diseases caused by predominantly pathogenic microorganisms that colonize the subgingival area and cause local and systemic elevations of proinflammatory cytokines such as Interleukin-6 (IL-6). Several lines of evidence established the association between periodontal and systemic diseases, including metabolic syndrome, diabetes, and cardiovascular disease. Because of the fact that both periodontal disease and PCOS are associated with systemic inflammation and insulin resistance, these two disorders may be linked through a common pathophysiologic pathway. A number of studies have indicated a possible relationship between PCOS and periodontal inflammation. Despite common risk factors, including oxidative stress, the relationship between chronic periodontitis (CP) and PCOS remains unclear. The aims of the study were to determine serum and saliva Endocan and IL-6 levels and to evaluate the correlation between these two biomarker in women with periodontal disease and PCOS.

NCT ID: NCT01895699 Completed - Clinical trials for Endothelial Function

The Effect of Contrast Agent on Endothelial Function in Healthy Men

Start date: July 2013
Phase: Phase 4
Study type: Interventional

Contrast medium is essential for diagnosis of many diseases. However, recent studies showed that contrast agents can induce renal injury and is associated with poor long-term clinical outcome, especially in diabetes. To date, no data are available on the relationship between contrast medium and endothelial function. Endothelial dysfunction is known to precede atherosclerosis and is considered a risk marker for future development of cardiovascular disease. Therefore, we hypothesized that contrast agents may induce endothelial dysfunction in healthy men. In addition, we hypothesized that contrast induced endothelial dysfunction via free radicals. Thus, we also test alpha-lipoic acid whether or not protect endothelial dysfunction induced by contrast agents.

NCT ID: NCT01657656 Completed - Tuberculosis Clinical Trials

Vitamin D Supplementations as Adjunct to Anti-Tuberculosis Drugs in Mongolia

Start date: October 2012
Phase: N/A
Study type: Interventional

Hypothesis That improving vitamin D status among TB patients will speed the pace of bacteriological cure, and will enhance immune responses to TB infection

NCT ID: NCT01231477 Completed - Sevoflurane Clinical Trials

Cytokines and Sevoflurane During Surgery

Start date: July 2009
Phase: N/A
Study type: Observational

The aim of the present study was to evaluate the effects of anaesthesia with sevoflurane and surgery on cytokines response.